FTSE 100 news / Companies and sectors / GSK / 13 October 2026
GSK (GSK): news on Tuesday 13 October 2026
+7.2 strongly positive
Coverage was dominated by GSK's $800 million Pennsylvania biomanufacturing and R&D expansion, alongside an expanded AI drug discovery deal with Chai Discovery. A report of a share dip after the Nuvalent deal was the only negative note.
What drove it
- $800M Pennsylvania expansion
- Chai Discovery AI deal
- Share price and analyst views
The 16 stories
- +8.7 GSK to invest $800M for new R&D, manufacturing hub in Pennsylvania
New R&D and manufacturing hub backed by $800M. - +8.3 GSK commits $800M to Pennsylvania biomanufacturing expansion
$800M biomanufacturing commitment signals growth investment. - +8.3 GSK to Invest $800M+ in Pennsylvania Expansion
$800M+ Pennsylvania expansion reported. - +8.3 GSK pledges $800M to add biologics production capabilities in Pennsylvania
Biologics production capability added via $800M pledge. - +8.3 Over $800 million investment from GSK to expand operations in Pennsylvania
Over $800M investment to expand operations. - +8.3 Pharma Giant GSK To Expand In Upper Merion, Investing $800 Million
$800M Upper Merion expansion is positive investment news. - +7.0 Chai Discovery and GSK Expand AI Drug Discovery Collaboration Following Successful Laboratory Evaluation
AI collaboration expanded after successful lab evaluation. - +6.7 Chai Discovery lands GSK deal after successful AI binder tests
AI discovery deal with Chai after successful tests. - +6.7 GSK planning new factory just outside West Conshohocken
New factory planned near West Conshohocken. - +6.3 GSK to Demolish, Rebuild on River Road for $800 Million Upper Merion Factory
Rebuilding for $800M factory, investment in capacity. - +5.8 GSK invests more than USD 800 million: JPMorgan targets GSK stock at 1,700 pence - ad-hoc-news.de
JPMorgan sets 1,700p target after investment news. - +3.3 Will GSK stock test GBX1,765 resistance as Chai Discovery research deal makes headlines?
Chai deal in headlines; resistance level in focus. - +2.5 GSK campus expansion includes demolition projects
Campus expansion work under way, part of investment plans. - −2.5 Is GSK (LSE:GSK) Shares' Dip After The Nuvalent Deal A Pipeline Story In Focus?
Share dip after Nuvalent deal, pipeline questions. - +0.5 Is the Options Market Predicting a Spike in GSK Plc Stock?
Options-activity piece, speculative and largely neutral. - +0.3 GSK stock costs EUR 20.89 with USD 93.2 billion market value - ad-hoc-news.de
Share price and market value snapshot, factual.
GSK: every day · Pharma and healthcare on 13 October 2026 · FTSE 100 overview for the day